184 related articles for article (PubMed ID: 11679109)
21. Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane.
Mortier S; De Vriese AS; McLoughlin RM; Topley N; Schaub TP; Passlick-Deetjen J; Lameire NH
J Am Soc Nephrol; 2003 May; 14(5):1296-306. PubMed ID: 12707398
[TBL] [Abstract][Full Text] [Related]
22. Longer-Period Effects of Bicarbonate/Lactate-Buffered Neutral Peritoneal Dialysis Fluid in Patients Undergoing Peritoneal Dialysis.
Hoshino T; Kaneko S; Minato S; Yanai K; Mutsuyoshi Y; Ishii H; Kitano T; Shindo M; Miyazawa H; Aomatsu A; Ito K; Ueda Y; Hirai K; Ookawara S; Morishita Y
Ther Apher Dial; 2018 Dec; 22(6):641-648. PubMed ID: 30014626
[TBL] [Abstract][Full Text] [Related]
23. Biocompatibility of new peritoneal dialysis solutions: clinical experience.
Garcia-Lopez E; Lindholm B; Tranaeus A
Perit Dial Int; 2000; 20 Suppl 5():S48-56. PubMed ID: 11229612
[TBL] [Abstract][Full Text] [Related]
24. Effects of a new bicarbonate/lactate-buffered neutral peritoneal dialysis fluid for peritoneal failure in patients undergoing peritoneal dialysis.
Hoshino T; Ishii H; Kitano T; Shindo M; Miyazawa H; Yamada H; Ito K; Ueda Y; Kaku Y; Hirai K; Mori H; Ookawara S; Tabei K; Morishita Y
Discov Med; 2016 Feb; 21(114):81-8. PubMed ID: 27011043
[TBL] [Abstract][Full Text] [Related]
25. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane.
Williams JD; Topley N; Craig KJ; Mackenzie RK; Pischetsrieder M; Lage C; Passlick-Deetjen J;
Kidney Int; 2004 Jul; 66(1):408-18. PubMed ID: 15200450
[TBL] [Abstract][Full Text] [Related]
26. Improved in vitro biocompatibility of bicarbonate-buffered peritoneal dialysis fluid.
Grossin N; Wautier MP; Wautier JL; Gane P; Taamma R; Boulanger E
Perit Dial Int; 2006; 26(6):664-70. PubMed ID: 17047233
[TBL] [Abstract][Full Text] [Related]
27. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
Plum J; Schoenicke G; Grabensee B
Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
[TBL] [Abstract][Full Text] [Related]
28. Glucose degradation products in peritoneal dialysis: from bench to bedside.
Jörres A
Kidney Blood Press Res; 2003; 26(2):113-7. PubMed ID: 12771536
[TBL] [Abstract][Full Text] [Related]
29. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis.
Higuchi C; Nishimura H; Sanaka T
Ther Apher Dial; 2006 Aug; 10(4):372-9. PubMed ID: 16911191
[TBL] [Abstract][Full Text] [Related]
30. Effects of new peritoneal dialysis solutions on leukocyte recruitment in the rat peritoneal membrane.
Mortier S; Faict D; Gericke M; Lameire N; De Vriese A
Nephron Exp Nephrol; 2005; 101(4):e139-45. PubMed ID: 16131808
[TBL] [Abstract][Full Text] [Related]
31. A study of the clinical and biochemical profile of peritoneal dialysis fluid low in glucose degradation products.
Lai KN; Lam MF; Leung JC; Chan LY; Lam CW; Chan IH; Chan HW; Li CS; Wong SS; Ho YW; Cheuk A; Tong MK; Tang SC
Perit Dial Int; 2012; 32(3):280-91. PubMed ID: 22045098
[TBL] [Abstract][Full Text] [Related]
32. Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells.
Witowski J; Korybalska K; Ksiazek K; Wisniewska-Elnur J; Jörres A; Lage C; Schaub TP; Passlick-Deetjen J; Breborowicz A; Grzegorzewska A; Ksiazek A; Liberek T; Lichodziejewska-Niemierko M; Majdan M; Rutkowski B; Stompór T; Sulowicz W
Nephrol Dial Transplant; 2004 Apr; 19(4):917-24. PubMed ID: 15031350
[TBL] [Abstract][Full Text] [Related]
33. Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children.
Schmitt CP; Haraldsson B; Doetschmann R; Zimmering M; Greiner C; Böswald M; Klaus G; Passlick-Deetjen J; Schaefer F
Kidney Int; 2002 Apr; 61(4):1527-36. PubMed ID: 11918761
[TBL] [Abstract][Full Text] [Related]
34. Reduced glucose degradation products in bicarbonate/lactate-buffered peritoneal dialysis solutions produced in two-chambered bags.
Cooker LA; Luneburg P; Faict D; Choo C; Holmes CJ
Perit Dial Int; 1997; 17(4):373-8. PubMed ID: 9284465
[TBL] [Abstract][Full Text] [Related]
35. What can we do to preserve the peritoneum?
Krediet RT; Zweers MM; van Westrhenen R; Ho-dac-Pannekeet MM; Struijk DG
Perit Dial Int; 2003 Dec; 23 Suppl 2():S14-9. PubMed ID: 17986535
[TBL] [Abstract][Full Text] [Related]
36. The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions.
ter Wee PM; Beelen RH; van den Born J
Kidney Int Suppl; 2003 Dec; (88):S75-83. PubMed ID: 14870880
[TBL] [Abstract][Full Text] [Related]
37. The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both?
Perl J; Nessim SJ; Bargman JM
Kidney Int; 2011 Apr; 79(8):814-24. PubMed ID: 21248712
[TBL] [Abstract][Full Text] [Related]
38. Effects of neutral pH and reduced glucose degradation products in a new peritoneal dialysis solution on morphology of peritoneal membrane in rats.
Ikehara O; Nishimura H; Naito T; Higuchi C; Sanaka T
Nephron Exp Nephrol; 2005; 100(1):e30-9. PubMed ID: 15731567
[TBL] [Abstract][Full Text] [Related]
39. "Biocompatible" Neutral pH Low-GDP Peritoneal Dialysis Solutions: Much Ado About Nothing?
Misra PS; Nessim SJ; Perl J
Semin Dial; 2017 Mar; 30(2):164-173. PubMed ID: 28251697
[TBL] [Abstract][Full Text] [Related]
40. Biocompatibility and tolerability of a purely bicarbonate-buffered peritoneal dialysis solution.
Weiss L; Stegmayr B; Malmsten G; Tejde M; Hadimeri H; Siegert CE; Ahlmén J; Larsson R; Ingman B; Simonsen O; van Hamersvelt HW; Johansson AC; Hylander B; Mayr M; Nilsson PH; Andersson PO; De los Ríos T
Perit Dial Int; 2009; 29(6):647-55. PubMed ID: 19910566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
